Discover ABECMA® (idecabtagene vicleucel), the first CAR T cell therapy for relapsed/refractory multiple myeloma, how it works, how it helps, and see patient stories. See Safety Info and Boxed WARNINGS.

ABECMA is a one-time infusion* created just for you. ABECMA, a CAR T cell therapy, uses cells from your body's immune system to fight multiple myeloma. ABECMA uses T cells that have been reprogrammed to find and destroy specific target cells, which may …

Learn what to expect during the ABECMA® (idecabtagene vicleucel) CAR T cell therapy treatment process for relapsed/refractory multiple myeloma. See Safety Info and Boxed WARNINGS.

See ABECMA® (idecabtagene vicleucel) clinical trial results for adults with relapsed/refractory multiple myeloma and how they responded to treatment. See Safety Info and Boxed WARNINGS.

See frequently asked questions about ABECMA® (idecabtagene vicleucel) and the CAR T cell therapy treatment journey. See Safety Info and Boxed WARNINGS.

Learn about possible ABECMA® (idecabtagene vicleucel) CAR T cell therapy side effects. See Safety Info and Boxed WARNINGS.

Use our ABECMA® (idecabtagene vicleucel) CAR T cell therapy treatment locator to find a treatment center near you. See Safety Info and Boxed WARNINGS.

Discover if ABECMA® (idecabtagene vicleucel) is the right option for you with an eligibility guide and learn how ABECMA® is different from a stem cell transplant. See Safety Info and Boxed WARNINGS.

Access helpful ABECMA® (idecabtagene vicleucel) resources for patients and caregivers. See Safety Info and Boxed WARNINGS.

What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least two kinds of treatment regimens that have not worked or have stopped working.